Ausgabe 1/2020
Inhalt (27 Artikel)
Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors
Laure Michaud, B. J. Beattie, T. Akhurst, M. Dunphy, P. Zanzonico, R. Finn, A. Mauguen, H. Schöder, W. A. Weber, A. B. Lassman, R. Blasberg
Comment on: “the FDG PET/CT score” for the diagnosis of malignant pleural effusion
Dharmender Malik
Fitting of late dynamic [18F]MK6240 PET scans for in vivo tau quantification
Eric Laffon, Sébastien Buj, Henri de Clermont, Roger Marthan
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients
Sofia Vaz, Boris Hadaschik, Michael Gabriel, Ken Herrmann, Matthias Eiber, Durval Costa
An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders
Abass Alavi, Søren Hess, Thomas J. Werner, Poul Flemming Høilund-Carlsen
Good clinical practice recommendations for the use of PET/CT in oncology
Pierre-Yves Salaün, Ronan Abgral, Olivier Malard, Solène Querellou-Lefranc, Gilles Quere, Myriam Wartski, Romain Coriat, Elif Hindie, David Taieb, Antoine Tabarin, Antoine Girard, Jean-François Grellier, Isabelle Brenot-Rossi, David Groheux, Caroline Rousseau, Désirée Deandreis, Jean-Louis Alberini, Caroline Bodet-Milin, Emmanuel Itti, Olivier Casasnovas, Françoise Kraeber-Bodere, Philippe Moreau, Arnaud Philip, Corinne Balleyguier, Alain Luciani, Florent Cachin
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations
Marius E. Mayerhoefer, Helmut Prosch, Lucian Beer, Dietmar Tamandl, Thomas Beyer, Christoph Hoeller, Dominik Berzaczy, Markus Raderer, Matthias Preusser, Maximilian Hochmair, Barbara Kiesewetter, Christian Scheuba, Ahmed Ba-Ssalamah, Georgios Karanikas, Julia Kesselbacher, Gerald Prager, Karin Dieckmann, Stephan Polterauer, Michael Weber, Ivo Rausch, Bernhard Brauner, Harald Eidherr, Wolfgang Wadsak, Alexander R. Haug
EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
Luca Giovanella, Giorgio Treglia, Ioannis Iakovou, Jasna Mihailovic, Frederik A. Verburg, Markus Luster
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
Frederik A. Verburg, Glenn Flux, Luca Giovanella, Douglas van Nostrand, Kristoff Muylle, Markus Luster
A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma
Chun-Ta Liao, Chia-Hsun Hsieh, Wen-Lang Fan, Shu-Hang Ng, Nai-Ming Cheng, Li-Yu Lee, Chuen Hsueh, Chien-Yu Lin, Kang-Hsing Fan, Hung-Ming Wang, Chih-Hung Lin, Chung-Kan Tsao, Chung-Jan Kang, Tuan-Jen Fang, Shiang-Fu Huang, Kai-Ping Chang, Li-Ang Lee, Ku-Hao Fang, Yu-Chien Wang, Lan-Yan Yang, Tzu-Chen Yen
Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma
Chih-Hua Yeh, Sheng-Chieh Chan, Chien-Yu Lin, Tzu-Chen Yen, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Kang-Hsing Fan, Hung-Ming Wang, Chun-Ta Liao, Shu-Hang Ng
Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer
Barbara J. Amorim, Vinay Prabhu, Sara S. Marco, Debra Gervais, Willian E. Palmer, Pedram Heidari, Mark Vangel, Philip J. Saylor, Onofrio A. Catalano
Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements
Lucia Baratto, Heying Duan, Riccardo Laudicella, Akira Toriihara, Negin Hatami, Valentina Ferri, Andrei Iagaru
First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
Jens Kurth, Bernd Joachim Krause, Sarah M. Schwarzenböck, Carina Bergner, Oliver W. Hakenberg, Martin Heuschkel
Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer
Francesco Ceci, Lorenzo Bianchi, Marco Borghesi, Giulia Polverari, Andrea Farolfi, Alberto Briganti, Riccardo Schiavina, Eugenio Brunocilla, Paolo Castellucci, Stefano Fanti
68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer
Daniela A. Ferraro, Urs J. Muehlematter, Helena I. Garcia Schüler, Niels J. Rupp, Martin Huellner, Michael Messerli, Jan Hendrik Rüschoff, Edwin E. G. W. ter Voert, Thomas Hermanns, Irene A. Burger
Dynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions
Ian Alberts, Christos Sachpekidis, Eleni Gourni, Silvan Boxler, Tobias Gross, George Thalmann, Kambiz Rahbar, Axel Rominger, Ali Afshar-Oromieh
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
Wojciech Cytawa, Anna Katharina Seitz, Stefan Kircher, Kazuhito Fukushima, Johannes Tran-Gia, Andreas Schirbel, Tomasz Bandurski, Piotr Lass, Markus Krebs, Wojciech Połom, Marcin Matuszewski, Hans-Jürgen Wester, Andreas K. Buck, Hubert Kübler, Constantin Lapa
18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
Ilhan Lim, Maria Liza Lindenberg, Esther Mena, Nicholas Verdini, Joanna H. Shih, Christian Mayfield, Ryan Thompson, Jeffrey Lin, Andy Vega, Marissa Mallek, Jacqueline Cadena, Carlos Diaz, Amir Mortazavi, Michael Knopp, Chadwick Wright, Mark Stein, Sumanta Pal, Peter L. Choyke, Andrea B. Apolo
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
Francesco Pasqualetti, Marco Panichi, Martina Sollini, Aldo Sainato, Luca Galli, Riccardo Morganti, Serena Chiacchio, Andrea Marciano, Roberta Zanca, Lorenzo Mannelli, Gabriele Coraggio, Andrea Sbrana, Paola Cocuzza, Sabrina Montrone, Davide Baldaccini, Alessandra Gonnelli, Alessandro Molinari, Martina Cantarella, Valentina Mazzotti, Sergio Ricci, Fabiola Paiar, Paola Anna Erba
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice
Sabina Dizdarevic, Ralph McCready, Sobhan Vinjamuri
An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT
Mine Araz, Cigdem Soydal, Cemaleddin Ozturk, Elgin Ozkan, Taner Demirer
18F-F13640 PET imaging of functional receptors in humans
Matthieu Colom, Nicolas Costes, Jérôme Redouté, Frédéric Dailler, Florent Gobert, Didier Le Bars, Thierry Billard, Adrian Newman-Tancredi, Luc Zimmer
18F-FDG PET/CT in lung B lymphoid hyperplasia-type Castleman disease
Paula Fernández-Rodríguez, Rosa Fernández López, Irene Acevedo Báñez, Javier Mohigefer Barrera, José Manuel Jiménez-Hoyuela García